Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.025 CAD
3.52 M CAD
25.39 M CAD
113.25 M
About MICROBIX BIOSYSTEMS
Sector
Industry
CEO
Cameron L. Groome
Website
Headquarters
Mississauga
Founded
1988
FIGI
BBG0086K0778
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. It operates through the Antigens, QAPs and DxTM, and Other segments. The Antigens, QAPs and DxTM segment includes the development, manufacturing and sales of products relating to the medical diagnostics industry. The Other segment deals with the development and commercialization of novel and proprietary products or technologies such as Kinlytic. The company was founded by William J. Gastle in 1988 and is headquartered in Mississauga, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MBX is 0.410 CAD — it has increased by 9.33% in the past 24 hours. Watch MICROBIX J stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange MICROBIX J stocks are traded under the ticker MBX.
MBX stock has risen by 18.84% compared to the previous week, the month change is a 32.26% rise, over the last year MICROBIX J has showed a 13.89% increase.
We've gathered analysts' opinions on MICROBIX J future price: according to them, MBX price has a max estimate of 0.90 CAD and a min estimate of 0.90 CAD. Watch MBX chart and read a more detailed MICROBIX J stock forecast: see what analysts think of MICROBIX J and suggest that you do with its stocks.
MBX stock is 8.64% volatile and has beta coefficient of −1.10. Track MICROBIX J stock price on the chart and check out the list of the most volatile stocks — is MICROBIX J there?
Today MICROBIX J has the market capitalization of 53.14 M, it has increased by 11.11% over the last week.
Yes, you can track MICROBIX J financials in yearly and quarterly reports right on TradingView.
MICROBIX J is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
MICROBIX J revenue for the last quarter amounts to 6.29 M CAD, despite the estimated figure of 5.60 M CAD. In the next quarter, revenue is expected to reach 5.80 M CAD.
MBX net income for the last quarter is 440.32 K CAD, while the quarter before that showed 246.75 K CAD of net income which accounts for 78.45% change. Track more MICROBIX J financial stats to get the full picture.
No, MBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MICROBIX J EBITDA is 5.52 M CAD, and current EBITDA margin is 21.73%. See more stats in MICROBIX J financial statements.
Like other stocks, MBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MICROBIX J stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MICROBIX J technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MICROBIX J stock shows the strong buy signal. See more of MICROBIX J technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.